Results 1 to 10 of about 16,305 (230)
Performance of tPSA and f/tPSA for prostate cancer in Chinese. A systematic review and meta-analysis [PDF]
Performing a systematic review and meta-analysis to evaluate the diagnostic performance of the total prostate-specific antigen (tPSA) tests for diagnosis of prostate cancer among Chinese. Literatures related to diagnosis of prostate cancer by tPSA and the ratio of free to total PSA (f/tPSA) being retrieved in five electronic databases.
Y, Wang +4 more
exaly +3 more sources
Background The ratio of fPSA/tPSA in the "grey zone" of tPSA with the concentration range between 4 ng/ml and 10 ng/ml is significant for diagnosis of prostate cancer, and highly efficiency quantification of the ratio of fPSA/tPSA remain elusive mainly ...
Biao Cai, Quan Jiang, Jianjun Sha
exaly +2 more sources
Mycobacterium tuberculosis bifunctional enzyme GlmU is a novel target for anti-TB drugs and is involved in glycosyl donor UDP-N-acetylglucosamine biosynthesis.
Yufang
exaly +3 more sources
Serum PSA levels fluctuations in patients with non–muscle-invasive bladder cancer (NMIBC) undergoing BCG therapy: a prospective study [PDF]
Background Intravesical bacillus Calmette–Guérin (BCG) therapy is the standard adjuvant treatment for intermediate-high risk non–muscle-invasive bladder cancer (NMIBC).
Seyyed Parham Ahmadi +3 more
doaj +2 more sources
Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination [PDF]
OBJECTIVES: The risks of identifying prostate cancer (PCa) in patients with serum total PSA (tPSA) between 4 and 10 ng/dl are between 25 and 35%. There are no data in Brazil showing the incidence of disease when all variables for PSA assessment are ...
Ari Miotto Jr +5 more
doaj +4 more sources
Diagnostic accuracy of PSA derivatives for prostate cancer in patients with low prostate-specific antigen levels [PDF]
Prostate-specific antigen (PSA) has long been used to screen for prostate cancer (PCa), yet its low diagnostic sensitivity in the so-called PSA “gray zone” often results in overdiagnosis or missed diagnoses.
Aihemaiti Kadeer +5 more
doaj +2 more sources
Cancer Status: Mocb and tPSA Prostate Cancer Markers
On the basis of the results of magneto-optical studies and their comparison with the outcome of medical tests magneto-optical MOCB and tPSA serum markers of cancer/recovered patient are presented. Status of the cancer serum donor is recognized as presence of the laevorotatory optical active molecules of (-)p density in serum while status of the ...
exaly +3 more sources
Use of a BMI-independent biomarker-based prostate cancer risk score to identify and triage individuals at risk of prostate disease [PDF]
Prostate cancer (PCa) is the second most common cause of cancer related deaths in men in the UK. A national screening programme for PCa does not exist due to the unsuitability of the total prostate specific antigen (tPSA) test which is not specific for ...
Joanne Watt +9 more
doaj +2 more sources
LIPID PROFILE IN DETERMINATION OF PROSTATIC PATIENT [PDF]
This study was included investigation the effects of prostate gland on lipid metabolism and other parameters Blood sample were collected from (37) male patient ( (20) cancer prostate ,(17) with benign prostate hypertrophy ) and (25) from control serum ...
THANA ISMAIL MUSTAFA
doaj +1 more source
Purpose: This study aimed to assess the impact of hemodialysis treatment and different dialysis membranes with varying surface areas on serum levels of total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), and the fPSA/tPSA ratio in patients undergoing hemodialysis treatment.
Nergiz ZORBOZAN +3 more
openaire +2 more sources

